GlassScriptPhysician profile
Robert L Mcdonald
NPI 1295807006
$9,635.70
in general payments reported to CMS, 2019-2025
48 companies · $1,838 in 2025
The $1,838 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,941 · 2020: $1,465 · 2021: $794 · 2022: $853 · 2023: $987 · 2024: $1,756 · 2025: $1,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,576 · Education: $5.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,575.80 |
| Education | $5.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,043.39 | 2019-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $917.36 | 2019-2025 | Ofev, Jascayd |
| Astrazeneca Pharmaceuticals LP | $840.62 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Regeneron Healthcare Solutions, INC. | $666.94 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $556.88 | 2019-2024 | Yupelri |
| Insmed, INC. | $430.83 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $387.69 | 2019-2025 | |
| United Therapeutics Corporation | $297.88 | 2019-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $252.51 | 2019-2024 | |
| Harmony Biosciences LLC | $203.57 | 2020-2025 | Wakix |
| Viatris Specialty LLC | $185.73 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $163.92 | 2020-2024 | Glassia |
| Sunovion Pharmaceuticals INC. | $154.42 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $145.59 | 2019-2024 | Opsumit, Uptravi |
| Genentech USA, INC. | $89.52 | 2019-2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $88.17 | 2019-2024 | |
| Amgen INC. | $79.53 | 2022-2025 | Tavneos, Tezspire |
| Teva Pharmaceuticals USA, INC. | $78.85 | 2020-2021 | |
| Axsome Therapeutics, INC. | $73.71 | 2023 | Sunosi |
| Novartis Pharmaceuticals Corporation | $64.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $53.01 | 2022-2023 | |
| Fisher & Paykel Healthcare INC | $51.77 | 2020-2024 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $49.42 | 2024-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $49.33 | 2019-2021 | |
| Grifols USA, LLC | $48.99 | 2021-2022 | |
| Shire North American Group INC | $48.30 | 2019 | |
| Baxter Healthcare | $47.13 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $41.63 | 2025 | Ohtuvayre |
| Advanced Respiratory, INC | $40.14 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $38.40 | 2020 | |
| Electromed, INC. | $36.50 | 2025 | Smartvest |
| Allergan, INC. | $33.27 | 2019 | |
| Tactile Systems Technology INC | $32.48 | 2025 | Flexitouch Plus, Nimbl |
| La Jolla Pharmaceutical Company | $32.25 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $31.71 | 2019 | |
| Lilly USA, LLC | $28.28 | 2025 | Zepbound |
| Veran Medical Technologies, INC. | $27.71 | 2020 | |
| Medtronic, INC. | $26.40 | 2025 | Illumisite |
| Mallinckrodt Hospital Products INC. | $24.61 | 2021 | |
| Vanda Pharmaceuticals INC. | $23.84 | 2024 | Hetlioz |
| Philips North America LLC | $23.50 | 2019 | |
| Inspire Medical Systems, INC. | $22.27 | 2025 | Inspire |
| Horizon Therapeutics Plc | $20.81 | 2019 | |
| Pulmonx Corporation | $20.50 | 2024 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Ethicon INC. | $18.13 | 2020 | |
| Resmed Corp | $17.07 | 2025 | |
| Breas Medical, INC. | $15.09 | 2023 | Vivo 45 Ls |
| Itamar Medical INC | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.